BPGbio Announces Publication of Pioneering Solid Tumor Study with BPM31510 IV using Patient Omics and Bayesian AI to Guide Clinical Development [Yahoo! Finance]
HCA Healthcare, Inc. (HCA)
Last hca healthcare, inc. earnings: 4/21 08:30 am
Check Earnings Report
US:NYSE Investor Relations:
investor.hcahealthcare.com
Company Research
Source: Yahoo! Finance
Phase 1a/1b study in 97 patients demonstrates mitochondrial metabolic reprogramming induced by BPM31510-IV and supports advancement in multiple aggressive solid tumor indications. BPM31510-IV has completed phase 2b enrollment for glioblastoma, completed phase 2a for pancreatic cancer Study data serves as fundamental clinical validation for NAi Interrogative Biology platform, enabling expanded pipeline development BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc. , a leading biology-first, AI-powered biopharmaceutical company focused on mitochondrial biology and protein homeostasis , today announced the publication of its Phase 1a/1b multi-center study evaluating BPM31510-IV , a first-in-class mitochondrial metabolic modulator , in 97 patients with advanced solid tumors in Cancer Research Communications The published findings—combined with computational analyses performed using BPGbio's NAi® Interrogative Biology® platform —served as a compelling biological foundation and
Show less
Read more
Impact Snapshot
Event Time:
HCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HCA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HCA alerts
High impacting HCA Healthcare, Inc. news events
Weekly update
A roundup of the hottest topics
HCA
News
- Dilon Technologies Announces FDA Approval and U.S. Launch of MarginProbe® 2, Next-Generation Intraoperative margin assessment technology [Yahoo! Finance]Yahoo! Finance
- HCA Healthcare (NYSE:HCA) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating.MarketBeat
- HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 86% Above Its Share Price [Yahoo! Finance]Yahoo! Finance
- HCA Healthcare (NYSE:HCA) had its price target raised by analysts at Robert W. Baird from $423.00 to $450.00. They now have a "neutral" rating on the stock.MarketBeat
- L1 Capital International Trimmed HCA Healthcare (HCA) Following Share Price Appreciation [Yahoo! Finance]Yahoo! Finance
HCA
Earnings
- 10/24/25 - Beat
HCA
Sec Filings
- 11/18/25 - Form 4
- 11/5/25 - Form 4
- 11/5/25 - Form 4
- HCA's page on the SEC website